Trade Mark Journal No.2025/022 30 May 2025

WO0000001853070 (5)

Office of origin: United States of America

Date of International Registration:2 April 2025
Date of designation in the UK: 2 April 2025
Image for mark 1853070 WAYBRI

International priority date claimed: 21 October 2024 (United States of America) (98812003)
Class 5
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories.

Edgewise Therapeutics, Inc.

Representative: Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI, 650 Page Mill Road, Wilson Sonsini Goodrich & Rosati, Palo Alto CA 94304, UNITED STATES OF AMERICA